Stringent regulatory environments can make OEMs reluctant to change processes and materials for approved medical devices
The emergence of new infections in India is a growing concern
Globally, colorectal cancer impacts 1.9 million people each year, standing as a leading cause of cancer mortality
Approval based on DUO-E trial results, which showed Imfinzi reduced the risk of disease progression or death by 58% vs. chemotherapy
NULIBRY is a first-in-class synthetic cPMP substrate replacement therapy to reduce the risk of mortality in patients with MoCD Type A
WINREVAIR is a breakthrough biologic for this rare, progressive disease
With just few days of treatment, the patient started responding well and finally complete clinical resolution of infection was attained
The talk show will be held monthly via Medanta's YouTube, Facebook and LinkedIn channe
MASH is a chronic and progressive liver disease characterised by fat accumulation and inflammation in the liver,
The initiative, “Change the Odds: Uniting to Improve Cancer Outcomes” aims to enhance awareness of and access to cancer screening, clinical trials and support
Subscribe To Our Newsletter & Stay Updated
